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ABSTRACT
Objective: To determine the prevalence of diabetic retinopathy and diabetic macular edema by
means of retinography in patients diagnosed with Type 2 diabetes mellitus according to time of
evolution and degree of vision loss with and without refractive correction. Method: A descriptive
cross-sectional study of 150 patients with Type 2 diabetes mellitus assessed in optometry in various
health centers from the Sanitary Jurisdiction of Tlalpan, Health Services of Mexico City. Results:
150 patients (70% women, 30% men) aged 60 (+/– 7.77) were diagnosed with Type 2 diabetes
mellitus, 52% of them with an evolution of 12.09 years (+/– 3.48). Of the total number of patients, 72.33% had retinopathy and/or diabetic macular edema lesions. The average visual acuity
improved from 0.62 (+/– 0.48) to 0.37 (+/– 0.38) with refractive correction, absolute disability
decreased by –18.76% and null or slight disability increased by 31.31%. Of the total population,
75.5% remained under monitoring in primary care, and 24.5% were referred to tertiary care in
ophthalmology. Conclusion: The strategic opportunity to combat vision loss due to retinopathy
and diabetic macular edema is found in its timely detection by health personnel trained in scrutiny and control at the primary care level, which would represent a decreased hospital load in
tertiary care, thereby reducing costs for the health systems, as well as cost-efficiency for the years
of sight gained and optimization of the patient’s global vision.
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RESUMEN
Objetivo: Determinar la prevalencia de retinopatía diabética y edema macular diabético
mediante retinografía en pacientes diagnosticados con diabetes mellitus tipo 2 según el
tiempo de evolución y el grado de pérdida de visión con corrección refractiva sin esta.
Método: Estudio descriptivo de corte transversal de 150 pacientes con diabetes mellitus tipo
2 evaluados en optometría, provenientes de diversos centros de salud pertenecientes a la
Jurisdicción Sanitaria de Tlalpan, Servicios de Salud de la Ciudad de México. Resultados:
150 pacientes (70% mujeres, 30% hombres) de 60 años (± 7,77) fueron diagnosticados con
diabetes mellitus tipo 2 (52%) con una evolución de 12,09 años (± 3,48). El 72,33% tiene
retinopatía y/o lesiones de edema macular diabético. La agudeza visual promedio mejoró
de 0,62 (± 0,48) a 0,37 (± 0,38) con corrección refractiva; la discapacidad absoluta disminuyó en −18,76% y la discapacidad nula o leve aumentó en 31,31%. Conclusión: Existe una
oportunidad estratégica para combatir la pérdida de visión debido a retinopatía y edema
macular diabético en la detección oportuna por parte del personal de salud capacitado
en examinación y control estratégicamente ubicado en el primer nivel de atención; esto
representaría una reducción de la carga hospitalaria del tercer nivel, reduciendo así los
costos para los sistemas de salud, lo cual significaría rentabilidad por los años de visión
ganados y optimizaría la visión global del paciente.

INTRODUCTION
Diabetes mellitus (DM) is a worldwide public
health problem; in fact, it is estimated that, in 2015,
415 million people were suffering from diabetes,
and that by 2040 that number will increase to 642
million, according to the International Diabetes
Federation (IDF) (1). According to the National
Health and Nutrition Survey, the prevalence of
diabetes in Mexico increased from 9.2% in 2012
to 9.4% in 2016, based on a previous diagnosis
of the disease (2). However, the actual number
of people suffering from DM is expected to be
twice as high, considering that many individuals
are unaware of their condition.
The IDF describes three main types of DM (1):
1) Type 1 or insulin-dependent diabetes. It is
caused by an autoimmune reaction that
compromises the beta cells of the pancreas,
leading to a deficient production of insulin
and thus requiring a daily application of this
hormone. It affects people at any age but it is
more common in children and young adults.
2) Diabetes type 2 (DM2), non-insulin dependent.
The result of the ineffective action of insulin,
it is the most common type of diabetes world-
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wide, caused mainly by being overweight and
having a sedentary lifestyle. The symptoms may
be detected after the disease has progressed
for several years and the first complications
manifest. DM2 used to manifest only in adults,
but nowadays it also manifests in children.
3) Gestational diabetes. It is characterized by
hyperglycemia during pregnancy and may
end after birth, increasing the risk factor for
developing DM in a period of 5 to 10 years.
Other specific types of DM develop due to alterations of the pancreas, associated with endocrine
diseases, genetic defects in the function of beta
cells, and genetic defects in the action of insulin.
Thus, diabetic retinopathy (DR) is the result of
microvascular alterations closely associated with
the type and time of evolution of DM, blood glucose (chronic hyperglycemia), blood pressure and
probably lipids, although the mechanism by which
hyperglycemia causes microvascular damage in
the retina is unknown (3,4).
Diabetic retinopathy and diabetic macular edema
(DME) are secondary complications to DM, being
one of the main causes of irreversible vision loss.
Literature lists different criteria for the classification of DR, some of which are so complex that
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eye, establishing percentages of visual decrease
and thus determining their degree of visual loss
(Table 2).
T able 1. Classification of diabetic retinopathy and diabetic
macular edema according to Scottish criteria (7,8)
Diabetic retinopathy
R0

Absence of diabetic retinopathy

R1

Hemorrhages, micro aneurysm, hard exudates, cottony exudates

R2

Four or more spot hemorrhages in a hemifield

R3

Four or more spot hemorrhages in a hemifield, venous rosary,
intraretinal vascular abnormalities

R4

Vitreous hemorrhage, preretinal hemorrhage, neovessels, l aser
traces

R6

Not valuable

M0

Absence of injuries within 2 disc diameters (DD) of the fovea

M1

Hard exudates and/or injuries > 1 DD and < 2DD

M2

Lesions in < 1DD of the center of the fovea

M6

Not valuable

Diabetic macular edema

T able 2. Classification criteria for global vision loss
according to Wecker’s scale (9): Materials and methods
Degree of disability

Loss of vision by DR and/or DME is the result of
injuries caused by DM and/or DME, with other
associated causes, such as refractive error, cataract,
and glaucoma, among others. The Wecker’s scale
(9) is a legal criterion used in Spain to determine
the overall visual disability of the individual, considering the visual acuity (VA) of the best and worst

Percentage of global visual loss

Null or mild disability

0–23

Partial disability

24–36

Total disability

37–50

Absolute disability

> 50

A transversal descriptive statistical analysis was
carried out between January 2016 and August
2017, in which 150 patients were evaluated (70%
women and 30% men), diagnosed with DM2 and
referred from family medicine to optometry, which
is part of different Health Centers of the Sanitary
Jurisdiction of Tlalpan, Mexico City.
A questionnaire was applied to patients under express verbal consent to obtain demographic data
and systemic pathologies. Patients who denied the
medical diagnosis of DM2 and those who did not
know its time of the evolution were selected. Monocular VA tests were performed with Snell Primer
(literate and illiterate) at a distance of 3 meters
with photopic illumination, static retinoscopy
tests with a test box and framework for obtaining
corrected VA images and eye fundus exploration
with non-mydriatic eye camera in retinographies
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In Scotland, the DR screening program was developed based on retinographies, a safe test that
can be performed without having to dilate the
pupil in most cases, which offers high sensitivity
and specificity for threats to vision resulting from
diseases. The program provides easy access, storage and transmission of images, which can be
consulted by one or several people in order to
guarantee assertiveness in the diagnosis, and it
is also cost-effective. The retinography, assessed
by certified personnel for scrutiny, contributes to
the management, control, follow-up or referral to
tertiary care ophthalmology, depending on the degree of severity. The Scottish classification system
of DR (7,8) is a simplified and clinically relevant
form for DR screening (Table 1).
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they are used for research purposes. The Early
Diabetic Retinopathy Study (ETDRS) has been
consolidated as the “gold standard” that makes it
possible to know about the development of the
disease, the risk factors, and the treatment based
on the degree of severity. Diabetic retinopathy was
classified as: without diabetic retinopathy (without
alterations), mild non-proliferative diabetic retinopathy (NPDR) (micro aneurysms), moderate
NPDR (more than just micro aneurysms, but less
severe NPDR), severe NPDR (any of the following:
more than 20 intraretinal hemorrhages in the four
quadrants, venous embrittlement in two or more
quadrants, or intraretinal microvascular anomalies in one or more quadrants), and proliferative
diabetic retinopathy (PDR) (neovascularization
or prerational or vitreous hemorrhage). On the
other hand, diabetic macular edema was classified,
as: without DME (DME absent) and clinically
significant DME (retinal thickening and/or hard
exudates at 500 microns or less to the macula) (5,6).
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with artifacts and refractive devices by indirect
ophthalmoscope and fundus examination system
for mobile devices for documentation of injuries
(Figure 1).

Out of 150 patients diagnosed with DM2 and
treated at primary care centers from the Sanitary
Jurisdiction of Tlalpan of the Government of Mexico City, 108.5 (72.33%) were found to have DR
and/or DME. According to the Scottish classification of DR and DME, an increase in severity
is observed in the age range (Table 3) according
to the time of evolution of diabetes.
T able 3. Distribution of findings of retinopathy and
diabetic macular edema, classified according to the Scottish
criterion by time of evolution of Type 2 Diabetes Mellitus
(n = 300 eyes)
Diabetes

Diabetic macular

Diabetic retinopathy

edema

evolution

F igure 1. 36-year-old female patient diagnosed with DM2
with 25 years of evolution. Left eye: VA 20/25 hemorrhage in
spot. Scottish classification R1, M1. Referral to tertiary care
Source: Retinography database of the Medical Specialty Units of Chronic
Diseases (UNEME ec) at Tlalpan.

The criterion according to the Scottish classification of RD (7,8) (Table 1) was used for weighing
of the degree, and the degree of visual incapacity
was determined based on Wecker’s scale (Table 2)
with and without refractive correction.
RESULTS
In the study, 150 patients from primary care centers
from the Sanitary Jurisdiction of Tlalpan of the
Government of Mexico City were seen. The patients were both female (70.0%) and male (30.0%),
97.99% with an average age of 60 years (+/– 7.77),
after a medical diagnosis of DM2 (58.0%) and in
comorbidity with Systemic Arterial Hypertension
(HAS) (52.0%), with an average time of evolution
of DM2 of 12.09 years (+/– 3.48).
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time

R0

R1

R2

R3

R4

R6

M0

M1

M2

M6

≤ 5 years

63

1

0

0

0

2

64

0

0

2

6 to 10 years

72

8

5

0

0

7

76

1

6

9

11 to 15 years

21

19

6

2

3

11

30

6

14

12

16 to 20 years

17

7

8

3

3

2

20

3

13

4

21 to 25 years

3

2

2

4

2

7

4

4

5

7

≥ 26 years

4

10

2

0

4

0

9

5

6

0

Source: CS TIII database, Dr. Castro Villagrana.

The descriptive statistical analysis of the prevalence at intervals of 5 years of diabetes evolution
showed an increased percentage of both DR and
DME in patients (Figure 2).
The loss of vision according to weighting with
Wecker’s scale (Figure 3) determined that absolute
disability is improvable, decreasing from 29.45%
to 10.69% with refractive correction, showing
a decrease of 18.76%; total disability improved
from 15.75% to 9.92%, showing a decrease of
5.83%; partial disability improved from 28.08% to
21.37%, showing a decrease of 6.37%; and null or
mild disability increased by 31.31%, going from
26.71% to 58.02.
Visual acuity in the Average MAR Log improved
from 0.62 (+/– 0.48) to 0.37 (+/– 0.38) with refrac
tive correction, reducing absolute disability by
–18.76% and increasing null or slight disability
by + 31.31%.
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80.0%
80.0%

66.1%

Percentage of patients

57,5%
55.0%
50.0%
51.6%

Diabetic Retinopathy
Diabetic Macular Edema

21.7%
17.4%

4.5%
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85.0%

3.0%
≤5 years

6 to 10 years

11 to 15 years

16 to 20 years

21 to 25 years

≥26 years

Diabetes evolution time

F igure 2. Increase in percentage of diabetic retinopathy and diabetic macular edema by time of evolution of diabetes
Source: CS TIII database, Dr. Castro Villagrana.

58.02%

Without refractive correction

29.45%

28.08%

26.71%
21.37%

15.75%
9.92%

Null or mild disability

Partial disability

Total disability

10.69%

Absolute disability

F igure 3. Distribution of visual disability in two groups, with and without refractive correction, based on Wecker’s scale
criterion
Source: CS TIII database, Dr. Castro Villagrana.
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Percentage of patients with visual disability

With refractive correction
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The referral to tertiary care in ophthalmology
(Figure 4) reflects a higher percentage of patients
under control in primary care (75.5%) versus referrals to tertiary care in ophthalmology (24.5%)
based on the Scottish RD Screening Criterion.
DISCUSSION
The early detection of DR is the responsibility
of the patient and of the relatives, caregivers and
health personnel who are in direct contact with
the patient, emphasizing the relevance of the annual visual examination, which allows detecting
injuries that compromise the patient’s vision in
a timely manner. It is also worth noting that DR
can be asymptomatic, meaning that the patient
has acceptable eyesight without any symptoms of
the disease, and that the continuity of the vision
is favored by a timely medical attention, which
would be less expensive and more effective.
The time of evolution of DM2 is a characteristic
that influences the increase in the percentage

of DR and/or DME (10,11). Previous studies of
prevalence of DR carried out in Mexico found a
prevalence of DR of 33.3% in the state of Hidalgo with an evolution of 9.9 years (12), of 71% in
Guanajuato with an evolution of up to 12 years
(13); in Durango, the prevalence of DR was of
21.3% in patients with an evolution of less than 5
years, and of 80.7% in patients with an evolution
of 15 years or more (14). The General Hospital
of Mexico reports a greater prevalence of DR in
patients with 15 years or more of evolution (15),
and in the present study the prevalence was of
21.7% in patients with evolution of 10 year, of
66.1% in patients with evolution of 15 years, and
of 85.0% in patients with evolution of 25 years
or more. The population of the studies carried
out in different Mexican states is heterogeneous
in terms of ethnic groups, age, and sex, and the
prevalence of DR tends to increase (Figure 5).
The implementation of screening strategies in
patients with DM in primary care would represent
an effective model (16-18), with elements such

83%

68%

Diabetic retinopathy

Percentage of patients

Diabetic macular edema

32%

17%

1st level of attention

Reference to 3rd level

F igure 4. Percentages of patients suffering from DM2 in follow-up control with Retinography by RD and/or DME in primary
care and referral to tertiary care in ophthalmology according to Scottish Criteria (n = 150 patients)
Source: CS TIII database, Dr. Castro Villagrana.
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30

CDMX

Time of evolution of diabetes

25

20

CDMX

Durango 14

15

Guanajuato 13

CDMX
10
Hidalgo 12

5

Durango 14
y = 18.389x + 3.1696
R2 = 0.6677

0
0.00

10.00

20.00

30.00

40.00

50.00

60.00

70.00

80.00

90.00

Percentage tendency of diabetic retinopathy

F igure 5. Percentage tendency of diabetic retinopathy due to time of evolution of diabetes in the Mexican population (12–14)

refractive correction may be subject to the degree
of visual impairment of the patient.

DR and/or DME leads to irreversible loss of vision (19), and refractive correction contributes to
decreasing visual disability despite injuries. Part
of the optometric model in care and rehabilitation of patients with DM is refractive correction,
which increased null or slight disability by +31.31%
and reduced absolute disability by –18.76%, thus
contributing to the patient’s being able to resume
domestic, trade, and recreational activities etc. It
also reduced the impact of depression and anxiety
caused by visual disability (20). Consideration for
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Referral to tertiary care in ophthalmology for DR
represents a greater cost when there is no effective DR screening model in primary care (21).
Optometrists must have the clinical sensitivity to
implement DR (22) screening, and so training
and certification should be the basic norm for
DR screening. Opportunistic screening would
be cost-effective for the years of vision loss saved.
CONCLUSIONS
Screening of DR by retinography in primary care
by trained optometrists aimed at DM2 patients
(n = 150) found that 72.33% of the patients s uffered
from DR and/or DME. Refractive correction favored null or mild disability by +31.31% and
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as medical history, visual examination, taking
appropriate quality retinographies, focusing on
patients without screening before or after being
diagnosed with DM2, implementing a periodic
review plan according to their stage or referral to
ophthalmology for a more thorough follow-up
and/or treatment of injuries.
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reduced absolute disability by –18.76%; moreover, average visual acuity, measured with the
LogMar chart, improved from 0.62 (+/– 0.48) to
0.37 (+/– 0.38) with refractive correction. Of the
total number of patients, 24.5% were referred to
tertiary care in ophthalmology and 75.5% were
seen and monitored in primary care.
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